Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunocompromised Patient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00707317
What this trial is testing

T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals

Who this might be right for
TuberculosisMonitoring, Immunologic
Tuberculosis Network European Trialsgroup 1,843
Not applicableStudy completedNCT04858607
What this trial is testing

Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals

Who this might be right for
Covid19Immunosuppression
Medical University of Graz 373
Large-scale testing (Phase 3)Study completedNCT02058589
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant

Who this might be right for
Herpes Zoster
GlaxoSmithKline 265
Large-scale testing (Phase 3)Not Yet RecruitingNCT07152613
What this trial is testing

Corticosteroids for PJP in Non-HIV Immunocompromised Adults

Who this might be right for
Pneumocystis Jiroveci Pneumonia
Qingyuan Zhan 240
Testing effectiveness (Phase 2)WithdrawnNCT01441024
What this trial is testing

DAS181 in Patients With Parainfluenza

Who this might be right for
Parainfluenza Infection
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableUnknownNCT02983851
What this trial is testing

Initial Ventilation Strategy for Adult Immunocompromised Patients With Acute Respiratory Failure

Who this might be right for
Immunocompromised PatientsAcute Respiratory Failure
Peking Union Medical College Hospital 238
Testing effectiveness (Phase 2)Study completedNCT03277703
What this trial is testing

Flu Vaccine Response in Patients on Biologic Therapies

Who this might be right for
Rheumatologic DisorderInflammatory Bowel DiseasesImmune Complex Diseases
Stony Brook University 30
Not applicableStudy completedNCT00904579
What this trial is testing

Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease

Who this might be right for
Immunocompromised HostOrgan TransplantationCancer
National Cancer Institute (NCI) 19,929,901
Not applicableUnknownNCT02104479
What this trial is testing

Diagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker Testing

Who this might be right for
Invasive AspergillosisPleural EffusionImmunosuppression
Heidelberg University 200
Not applicableWithdrawnNCT05672654
What this trial is testing

Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients

Who this might be right for
HIV SeropositivityImmunodeficiencyVaccination Reaction+1 more
University Hospital, Ghent
Not applicableAvailableNCT06478641
What this trial is testing

Expanded Use in Persistent (B. Microti) Babesiosis

Who this might be right for
Persistent Babesiosis
60 Degrees Pharmaceuticals LLC
Not applicableStudy completedNCT01947465
What this trial is testing

Immunogenicity and Safety of Vaccinations in Immunocompromised Persons

Who this might be right for
Arthritis, RheumatoidSpondylarthritisVasculitis
University of Zurich 645
Early research (Phase 1)Active Not RecruitingNCT07709637
What this trial is testing

Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients

Who this might be right for
COVID-19COVID-19 (SARS-CoV-2 Infection)
LucasBio 1
Not applicableStudy completedNCT00002062
What this trial is testing

Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients

Who this might be right for
CryptosporidiosisHIV Infections
Rhone-Poulenc Rorer
Not applicableUnknownNCT01902030
What this trial is testing

Evaluation of Performance of An Aspergillus PCR in Tissue and Pleural Effusion Samples of Immunocompromised Patients

Who this might be right for
AspergillosisImmunosuppression
Heidelberg University 100
Testing effectiveness (Phase 2)Temporarily pausedNCT07042295
What this trial is testing

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

Who this might be right for
Locally Recurrent Skin Squamous Cell CarcinomaMetastatic Skin Squamous Cell Carcinoma
National Cancer Institute (NCI) 86
Large-scale testing (Phase 3)Study completedNCT00001757
What this trial is testing

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Who this might be right for
Mycoses
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT04380701
What this trial is testing

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

Who this might be right for
Infections, RespiratoryVirus DiseasesInfection Viral+3 more
BioNTech SE 512
Testing effectiveness (Phase 2)Ended earlyNCT04364178
What this trial is testing

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus
Jessie L. Alexander, MD 8
Not applicableStudy completedNCT00002308
What this trial is testing

Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Next Page